Advanced glycation end products and its soluble receptor in AOSD pathogenic role
碩士 === 國立中興大學 === 生命科學院碩士在職專班 === 101 === Adult onset Still’s disease (AOSD) is a chronic inflammatory disease characterized by fever of unknown origin, arthritis, and skin rash. However the etiopathogenesis of AOSD remains unclear. Studies have shown that the levels of advanced glycation end produc...
Main Authors: | Yen- Ching Wu, 吳燕晴 |
---|---|
Other Authors: | Der- Yuan Chen |
Format: | Others |
Language: | zh-TW |
Published: |
2013
|
Online Access: | http://ndltd.ncl.edu.tw/handle/64966087533341905520 |
Similar Items
-
Functional Role of Soluble Receptor for Advanced Glycation End Products in Acute Stroke
by: Sung-Chun Tang, et al.
Published: (2013) -
Statins stimulate the production of a soluble form of the receptor for advanced glycation end products
by: Patricia Quade-Lyssy, et al.
Published: (2013-11-01) -
Decreased Soluble Receptor of Advanced Glycation End Product Levels Correlated with Inflammation in Silicosis
by: Heliang Liu, et al.
Published: (2020-01-01) -
Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome
by: Louise J. N. Jensen, et al.
Published: (2015-01-01) -
Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD
by: Katherine A. Pratte, et al.
Published: (2021-04-01)